It is a modified analog of glucagon-like peptide-1 (GLP-1), a naturally occurring incretin hormone involved in glucose signaling and energy regulation
Shin S, Le Lay J, Everett LJ, Gupta R, Rafiq K, Kaestner KH
Originally developed to treat Type 2 diabetes under the names Ozempic and Weygovy, Semaglutide is now taking center stage as a treatment for obesity and excess weight
We are committed to providing our clients with the most advanced and effective weight management solutions
These findings were presented May 1114 at Heart Failure 2024, a scientific congress of the European Society of Cardiology (ESC)
Cholelithiasis in Patients Treated With Glucagon-Like Peptide-1 Receptor: An Updated Meta-Analysis of Randomized Controlled Trials